Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Pulse Biosciences Inc PLSE

Healthcare Medical Devices
Pulse Biosciences, Inc. is a bioelectric medicine company. The Company’s proprietary CellFX nsPFA technology delivers nanosecond pulses of electrical energy to non-thermally clear cells while sparing adjacent noncellular tissue. The Company is engaged in the development of its CellFX nsPFA technology for use in the treatment of atrial fibrillation and in a select few other markets where it... see more

Recent & Breaking News (NDAQ:PLSE)

Pulse Biosciences Quarterly Investor and Analyst Conference Call

Business Wire July 27, 2017

Investor Network: Pulse Biosciences, Inc. to Host Earnings Call

Accesswire July 27, 2017

Pulse Biosciences Announces Treatment of First Patient in Study to Evaluate the Safety and Efficacy of Novel Nano-Pulse Stimulation Technology for Seborrheic Keratosis Lesions

Business Wire June 6, 2017

Kerrisdale Capital Issues Negative Report on Pulse Biosciences, Inc. and Announces Conference Call

PR Newswire May 9, 2017

Pulse Biosciences Quarterly Investor Conference Call

Business Wire May 4, 2017

Investor Network: Pulse Biosciences, Inc. to Host Earnings Call

Accesswire May 4, 2017

Pulse Biosciences to Host Quarterly Investor Conference Call on May 4, 2017

Business Wire April 17, 2017

Pulse Biosciences Quartery Investor Conference Call

Business Wire March 14, 2017

Pulse Biosciences Submits 510(k) Application to FDA for PulseTx™ System

Business Wire March 14, 2017

Pulse Biosciences to Host Investor Conference Call on March 14, 2017

Business Wire March 1, 2017

Pulse Biosciences Announces Healthcare Executives and Entrepreneurs Robert Duggan and Dr. Maky Zanganeh Have Acquired a Combined Interest of 17.1% of the Company

Business Wire February 10, 2017

Pulse Biosciences Quarterly Nano-Pulse Stimulation (NPS) Update

Business Wire November 14, 2016

Pulse Biosciences Announces First Clinical Use of the Proprietary PulseTx Platform in a Pilot Study in Dermatology

Business Wire November 14, 2016

Pulse Biosciences Announces New Data That Reinforce Potential Immuno-Oncology Benefits of Nano-Pulse Stimulation Technology

Business Wire November 11, 2016

Pulse Biosciences to Host Third Quarter Investor Conference Call on November 14, 2016

Business Wire November 2, 2016

Pulse Biosciences to Present New Data at the Society for Immunotherapy in Cancer Annual Meeting

Business Wire October 18, 2016

Stocks Hitting 52-Week Highs

Benzinga.com  September 12, 2016

Pulse Biosciences Provides Overview of Corporate Strategy and Updates on Clinical Development for Novel PulseTx Platform

Business Wire September 7, 2016

Pulse Biosciences Appoints Holly Hartman as Vice President of Business Development and Corporate Strategy

Business Wire August 30, 2016

Pulse Biosciences Appoints Edward Ebbers as Vice President and General Manager of Dermatology Products

Business Wire August 24, 2016